Zari Tehrani MSc, PhD, MRSC

Dr. Zari Tehrani holds BSc, MSc, MBL, Mrs, Ph.D. in Nanotechnology and MRSC. She was awarded as a Research Fellow by Sêr Cymru II. She was working as a post-doctorate researcher at Swansea University since 2011. Her Ph.D. was in the Functionalisation of Semiconductor Surfaces for Biosensor Applications. In 2013 she joined the WCPC, where she established herself as an autonomous researcher - developing graphene technologies for a number of new applications. In the context of printing, she developed new skills in printing technology and the fabrication of functional devices. This was demonstrated successfully by the fabrication of one of the first all-printed rechargeable thin film batteries. She had experience working on Bio-compatible Cellulose nanostructures for advanced wound healing applications by printing techniques. She has a unique set of talents, in that she has scientific expertise in biosciences and printing. She is an outstanding researcher within SU's College of Engineering, who has made significant contributions to biosensor research. Zari played an integral role within the biosensor team, where she helped in developing graphene and microfluidics technology through EPSRC, Innovate UK, and Marie Curie sensor projects. The group went on to develop the world's first graphene biosensor, which they are now adapting into platform technology for applications in diagnostics related to dementia, cardiac disease, and hepatitis. The projects that Zari worked on led to securing grant income of more than £4 million, 2 granted patents (WO2011004136 and P100072GB), and the publication of more than 70 papers from the group. Zari has a very impressive multi-disciplinary track record in biosensors development, with a genuine 4 publications in 2D Materials and several other publications, reporting her internationally leading research 3,4 Zari has experience in both the WCPC and CNH research centers and her research resonates strongly with their strategically important activities in graphene, printed batteries and lab on chip technology. Zari's research is also highly industrially relevant to several companies including Biovici, Algipharma, Semefab, and Haydale, which is likely to contribute to a REF impact case study. Zari has published more than 20 papers.